FindTrial
Sign In

Comparison of Intrathecal 1% Chloroprocaine and 0.5% Hyperbaric Bupivacaine for Infraumbilical surgeries - A prospective randomized trial.

Comparison of Intrathecal 1% Chloroprocaine and 0.5% Hyperbaric Bupivacaine for Infraumbilical surgeries - A prospective randomized double blind study.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/11/016249
Enrollment
90
Registered
2018-11-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R688- Other general symptoms and signs

Interventions

Intervention1: Dr.Devraj Yadav: Single dose,intrathecal route, 1% Chloroprocaine (3 ml/30mg)and o.5% Hyperbaric Bupivacaine (3 ml/15mg) PG(student)JLN Medcal college,Ajmer,Rajasthan Control Interven

Sponsors

Department of Anaesthesia
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient age between 18 - 60 years. ASA physical Status 1 & 2

Exclusion criteria

Exclusion criteria: Age 60 years ASA physical status 3,4,5& 6 Patients refusal Patient sensitive/ allergic to local anaesthetic agent. Patient with peripheral sensorineural deficit Patient on anticoagulants Infection at the site of lumbar puncture

Design outcomes

Primary

MeasureTime frame
Onset and duration of sensory blockTimepoint: 6 months—

Secondary

MeasureTime frame
Adverse effectsTimepoint: 6 months;Duration of analgesiaTimepoint: 6 months;Duration of motor blockTimepoint: 6 months;Hemodynamic effectsTimepoint: 6 months;Time to return of voiding function post-operatively.Timepoint: 6 months—

Countries

India

Contacts

Public ContactDrArvind Khare

JLN Medical college,Ajmer

arvindkhare68@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026